HK Stock MarketDetailed Quotes

00883 CNOOC

Watchlist
  • 19.000
  • +0.280+1.50%
Not Open Apr 25 16:09 CST
903.77BMarket Cap6.23P/E (TTM)

CNOOC Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
14.08%111.47B
-1.33%416.61B
-1.39%306.82B
-5.09%192.06B
7.50%97.71B
71.56%422.23B
--311.15B
83.57%202.36B
--90.9B
58.40%246.11B
Operating income
14.08%111.47B
-1.33%416.61B
-1.39%306.82B
-5.09%192.06B
7.50%97.71B
71.56%422.23B
311.15B
83.57%202.36B
90.9B
58.40%246.11B
Operating expenses
-4.61%-51.91B
-9.15%-154.65B
-31.18%-49.63B
-141.69B
-37.83B
Gross profit
23.85%59.55B
-10.20%152.17B
-9.39%48.08B
169.46B
53.07B
Selling expenses
-1.14%-884M
-4.62%-10.95B
-5.60%-2.62B
-13.98%-4.99B
-13.51%-874M
-16.82%-10.47B
---2.48B
-13.07%-4.38B
---770M
-1.59%-8.96B
Administrative expenses
-22.51%-1.62B
----
-16.41%-4.78B
----
-7.12%-1.32B
----
---4.1B
----
---1.24B
----
Research and development expenses
4.27%-336M
----
-46.43%-1.19B
----
-56.00%-351M
----
---812M
----
---225M
----
Profit from asset sales
50.00%3M
----
-114.29%-2M
----
-33.33%2M
----
--14M
----
--3M
----
Depreciation and amortization
----
-9.70%-68.95B
----
-14.34%-33.74B
----
-9.81%-62.85B
----
-2.04%-29.51B
----
-9.43%-57.24B
Revaluation surplus
-89.87%56M
----
222.00%483M
----
1,070.18%553M
----
--150M
----
---57M
----
-Changes in the fair value of other assets
-89.87%56M
----
222.00%483M
----
1,070.18%553M
----
--150M
----
---57M
----
Impairment and provision
-2,400.00%-25M
-440.09%-3.6B
-184.82%-319M
-191.26%-300M
66.67%-1M
91.63%-666M
---112M
-80.70%-103M
---3M
-53.05%-7.96B
-Other impairment is provision
-2,400.00%-25M
-440.09%-3.6B
-184.82%-319M
-191.26%-300M
66.67%-1M
91.63%-666M
---112M
-80.70%-103M
---3M
-53.05%-7.96B
Special items of operating profit
-36.79%615M
-3.58%-141.01B
1.35%3.99B
2.72%-60.39B
666.14%973M
-110.07%-136.14B
--3.94B
-129.43%-62.08B
--127M
-42.57%-64.81B
Operating profit
20.76%52.29B
-13.22%167.77B
-11.90%133.92B
-13.18%84.27B
-7.16%43.3B
101.42%193.33B
152B
113.57%97.06B
46.64B
163.76%95.98B
Financing income
----
61.24%4.81B
----
106.28%2.3B
----
122.22%2.98B
----
105.72%1.12B
----
-8.96%1.34B
Financing cost
532.65%310M
11.17%-5.35B
65.75%-744M
9.82%-2.8B
107.17%49M
-0.13%-6.03B
---2.17B
-9.41%-3.11B
---683M
2.76%-6.02B
Share of profits of associates
----
28.21%850M
----
40.07%423M
----
8.51%663M
----
-17.26%302M
----
257.31%611M
Share of profit from joint venture company
----
-13.38%1.08B
----
-24.69%424M
----
570.94%1.25B
----
441.35%563M
----
67.00%-265M
Special items of earning before tax
23.08%-60M
48.12%3.82B
-61.19%-216M
2.19%2B
-178.57%-78M
-38.16%2.58B
---134M
45.00%1.96B
---28M
7.94%4.17B
Earning before tax
21.42%52.54B
-11.19%172.97B
-11.18%132.96B
-11.52%86.62B
-5.79%43.27B
103.26%194.77B
149.69B
117.68%97.9B
45.93B
174.50%95.82B
Tax
-14.79%-12.81B
7.93%-48.88B
13.78%-35.3B
12.07%-22.87B
4.01%-11.16B
-108.09%-53.09B
---40.94B
-123.36%-26.02B
---11.63B
-156.40%-25.51B
After-tax profit from continuing operations
23.72%39.73B
-12.41%124.09B
-10.21%97.66B
-11.32%63.75B
-6.39%32.11B
101.51%141.68B
108.76B
115.70%71.88B
34.3B
181.72%70.31B
Earning after tax
23.72%39.73B
-12.41%124.09B
-10.21%97.66B
-11.32%63.75B
-6.39%32.11B
101.51%141.68B
108.76B
115.70%71.88B
34.3B
181.72%70.31B
Minority profit
275.00%7M
1,173.91%247M
240.00%14M
-225.00%-13M
-300.00%-4M
-76.92%-23M
---10M
-33.33%-4M
---1M
---13M
Profit attributable to shareholders
23.69%39.72B
-12.60%123.84B
-10.23%97.65B
-11.30%63.76B
-6.38%32.11B
101.51%141.7B
108.77B
115.69%71.89B
34.3B
181.78%70.32B
Basic earnings per share
23.53%0.84
-14.19%2.6
-12.39%2.05
-14.65%1.34
-11.69%0.68
92.99%3.03
2.34
109.33%1.57
0.77
180.36%1.57
Diluted earnings per share
23.53%0.84
-14.19%2.6
-12.39%2.05
-14.65%1.34
-11.69%0.68
92.99%3.03
2.34
109.33%1.57
0.77
180.36%1.57
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS and HKAS
CAS (2007)
IAS and HKAS
CAS (2007)
IAS and HKAS
CAS (2007)
IAS and HKAS
CAS (2007)
IAS and HKAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Ernst & Young (Special General Partnership), Ernst & Young
--
--
--
Ernst & Young (Special General Partnership), Ernst & Young
--
--
--
Ernst & Young (Special General Partnership), Ernst & Young
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover 14.08%111.47B-1.33%416.61B-1.39%306.82B-5.09%192.06B7.50%97.71B71.56%422.23B--311.15B83.57%202.36B--90.9B58.40%246.11B
Operating income 14.08%111.47B-1.33%416.61B-1.39%306.82B-5.09%192.06B7.50%97.71B71.56%422.23B311.15B83.57%202.36B90.9B58.40%246.11B
Operating expenses -4.61%-51.91B-9.15%-154.65B-31.18%-49.63B-141.69B-37.83B
Gross profit 23.85%59.55B-10.20%152.17B-9.39%48.08B169.46B53.07B
Selling expenses -1.14%-884M-4.62%-10.95B-5.60%-2.62B-13.98%-4.99B-13.51%-874M-16.82%-10.47B---2.48B-13.07%-4.38B---770M-1.59%-8.96B
Administrative expenses -22.51%-1.62B-----16.41%-4.78B-----7.12%-1.32B-------4.1B-------1.24B----
Research and development expenses 4.27%-336M-----46.43%-1.19B-----56.00%-351M-------812M-------225M----
Profit from asset sales 50.00%3M-----114.29%-2M-----33.33%2M------14M------3M----
Depreciation and amortization -----9.70%-68.95B-----14.34%-33.74B-----9.81%-62.85B-----2.04%-29.51B-----9.43%-57.24B
Revaluation surplus -89.87%56M----222.00%483M----1,070.18%553M------150M-------57M----
-Changes in the fair value of other assets -89.87%56M----222.00%483M----1,070.18%553M------150M-------57M----
Impairment and provision -2,400.00%-25M-440.09%-3.6B-184.82%-319M-191.26%-300M66.67%-1M91.63%-666M---112M-80.70%-103M---3M-53.05%-7.96B
-Other impairment is provision -2,400.00%-25M-440.09%-3.6B-184.82%-319M-191.26%-300M66.67%-1M91.63%-666M---112M-80.70%-103M---3M-53.05%-7.96B
Special items of operating profit -36.79%615M-3.58%-141.01B1.35%3.99B2.72%-60.39B666.14%973M-110.07%-136.14B--3.94B-129.43%-62.08B--127M-42.57%-64.81B
Operating profit 20.76%52.29B-13.22%167.77B-11.90%133.92B-13.18%84.27B-7.16%43.3B101.42%193.33B152B113.57%97.06B46.64B163.76%95.98B
Financing income ----61.24%4.81B----106.28%2.3B----122.22%2.98B----105.72%1.12B-----8.96%1.34B
Financing cost 532.65%310M11.17%-5.35B65.75%-744M9.82%-2.8B107.17%49M-0.13%-6.03B---2.17B-9.41%-3.11B---683M2.76%-6.02B
Share of profits of associates ----28.21%850M----40.07%423M----8.51%663M-----17.26%302M----257.31%611M
Share of profit from joint venture company -----13.38%1.08B-----24.69%424M----570.94%1.25B----441.35%563M----67.00%-265M
Special items of earning before tax 23.08%-60M48.12%3.82B-61.19%-216M2.19%2B-178.57%-78M-38.16%2.58B---134M45.00%1.96B---28M7.94%4.17B
Earning before tax 21.42%52.54B-11.19%172.97B-11.18%132.96B-11.52%86.62B-5.79%43.27B103.26%194.77B149.69B117.68%97.9B45.93B174.50%95.82B
Tax -14.79%-12.81B7.93%-48.88B13.78%-35.3B12.07%-22.87B4.01%-11.16B-108.09%-53.09B---40.94B-123.36%-26.02B---11.63B-156.40%-25.51B
After-tax profit from continuing operations 23.72%39.73B-12.41%124.09B-10.21%97.66B-11.32%63.75B-6.39%32.11B101.51%141.68B108.76B115.70%71.88B34.3B181.72%70.31B
Earning after tax 23.72%39.73B-12.41%124.09B-10.21%97.66B-11.32%63.75B-6.39%32.11B101.51%141.68B108.76B115.70%71.88B34.3B181.72%70.31B
Minority profit 275.00%7M1,173.91%247M240.00%14M-225.00%-13M-300.00%-4M-76.92%-23M---10M-33.33%-4M---1M---13M
Profit attributable to shareholders 23.69%39.72B-12.60%123.84B-10.23%97.65B-11.30%63.76B-6.38%32.11B101.51%141.7B108.77B115.69%71.89B34.3B181.78%70.32B
Basic earnings per share 23.53%0.84-14.19%2.6-12.39%2.05-14.65%1.34-11.69%0.6892.99%3.032.34109.33%1.570.77180.36%1.57
Diluted earnings per share 23.53%0.84-14.19%2.6-12.39%2.05-14.65%1.34-11.69%0.6892.99%3.032.34109.33%1.570.77180.36%1.57
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IAS and HKASCAS (2007)IAS and HKASCAS (2007)IAS and HKASCAS (2007)IAS and HKASCAS (2007)IAS and HKAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Ernst & Young (Special General Partnership), Ernst & Young------Ernst & Young (Special General Partnership), Ernst & Young------Ernst & Young (Special General Partnership), Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg